In recent years, a large number of multidrug-resistant Klebsiella pneumonia has been revealed bearing different variants of blaSHV. In the current study, antibiotic sensitivity test and the rate and molecular characterization of three...
moreIn recent years, a large number of multidrug-resistant Klebsiella pneumonia has been revealed bearing different variants of blaSHV. In the current study, antibiotic sensitivity test and the rate and molecular characterization of three common beta-lactam resistance genes, blaSHV, blaOXA, and blaCTX were investigated in K. pneumonia isolated from layer chickens in Sulaimani city/Iraq. Furthermore, the molecular characterization of blaSHV was studied. The highest rate of resistance was to ceftazidime (92.9%) and cefotaxime (82.3%), while the lowest rate was found against meropenem (4.7) and imipenem (8.2%). Among 85 isolates of K. pneumonia, 33 isolates (33.8%) had CTX gene which is the highest rate among the three resistance genes. The second most common resistance gene was SHV gene, 22.3%, and OXA gene showed the lowest rate 11.7%. After PCR amplification and sequencing, it was revealed that a novel variant of blaSHV, SHV-Suly213 was recovered from K. pneumonia and it exists in the studied area. The new variant contains a hybrid mutation which is composed of a mixture of nucleotide sequence of previously known blaSHV, SHV-1 and SHV-213. Phylogenetic tree shows that the novel SHV is more closely related to SHV-213; therefore, it was named SHV-Suly213. The bacteria were resistant to ceftriaxone and cefotaxime, but meropenem was still active against the bacteria. In conclusion, the current study discovered a new variant of blaSHV, SHV-Suly213. The resistance gene compromised of mixed sequences (hybrid) of both SHV-1 and SHV-2113 that contain three nucleotide mutations in comparison to them. The bacteria are resistant to many beta-lactam antibiotics such as ceftriaxone and cefotaxime, but not meropenem.